IME says AI agents are live; EBITDA up 4x and raises growth targets
ImExHS says AI agents are now live in hospitals, citing improved EBITDA and stable recurring revenue. It targets 8—16% revenue growth and 48—66% EBITDA growth, with Colombia collections a key risk.